MEZZION PHARMA CO.,LTD.

(A140410)
  Rapport
Cours en clôture Korea Stock Exchange  -  05/07/2022
19450.00 KRW   +14.75%
31/05Mezzion Pharma Co.,Ltd. reçoit une autorisation claire de la FDA pour l'homologation de l'Udenafil pour les maladies cardiaques à ventricule unique
CI
11/05Mezzion Pharma Co.,Ltd. annonce ses résultats pour le premier trimestre se terminant le 31 mars 2022
CI
23/03Mezzion Pharma Co.,Ltd. annonce ses résultats pour l'année complète se terminant le 31 décembre 2021
CI
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesFonds 
SynthèseToute l'actualitéAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur MEZZION PHARMA CO.,LTD.
31/05Mezzion Pharma Co.,Ltd. Receives Clear FDA Path Forward for the Approval of Udenafil fo..
11/05Mezzion Pharma Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, ..
23/03Mezzion Pharma Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2..
2021Mezzion Pharma Announces Positive Data Presented to FDA in Type C Meeting
2021Mezzion Pharma Co.,Ltd. announced that it has received KRW 20 billion in funding
2021Mezzion Pharma Co.,Ltd. announced that it expects to receive KRW 20 billion in funding
2021Mezzion Appoints William Breitenbach as Chief Commercial Officer for Mezzion's Global C..
2021Mezzion's New Drug Application for Its Orphan Drug Udenafil for the Treatment of Single..
2021Mezzion Pharma Co. Ltd. Announces Re-Submission of New Drug Application for its Orphan ..
2020Mezzion Pharma Co. Ltd. Announces Submission of New Drug Application for its Orphan Dru..
2020Mezzion Pharma's Announces Results from the Pivotal 400-Subject Phase 3 Fuel Trial
2019Mezzion Pharma Announces the Presentation of the FUEL Trial Data at the American Heart ..
2019Mezzion Pharma Co.,Ltd. Announces Top Line Data from FUEL Will Be Presented at the Amer..
2019Mezzion Pharma Co.,Ltd. Announces Positive Results from the Fontan Udenafil Exercise Lo..
2016Mezzion Pharma Co.,Ltd. announced that it has received KRW 15 billion in funding from a..
2016Mezzion Pharma Co.,Ltd. announced that it expects to receive KRW 15 billion in funding ..
2016Mezzion Pharma and NHLBI Initiate Enrollment in a Pivotal Phase 3 Clinical Trial of Ude..
2016Mezzion Pharma Co. Ltd. Receives Special Protocol Assessment Agreement From FDA For Ude..
2015Tranche Update on Mezzion Pharma Co.,Ltd.'s Equity Buyback Plan announced on November 1..
2015Mezzion Pharma Co.,Ltd. authorizes a Buyback Plan.
2015Mezzion Pharma Co.,Ltd. announces an Equity Buyback for 180,505 shares.
2015MEZZION PHARMA CO.,LTD.(KOSDAQ : A140410) added to S&P Global BMI Index
2015Dong-A PharmTech Co. Ltd. cancelled the acquisition of medical equipment sales business..
2015Mezzion Pharma Co.,Ltd. announced that it has received KRW 42 billion in funding from a..
2015Mezzion Pharma Co.,Ltd. announced that it expects to receive KRW 42 billion in funding ..
2015Tranche Update on Mezzion Pharma Co.,Ltd.'s Equity Buyback Plan announced on April 6, 2..
2015Mezzion Pharma Co.,Ltd.'s Equity Buyback announced on April 6, 2015 has closed with 106..
2015Mezzion Pharma Co.,Ltd. authorizes a Buyback Plan.
2015Mezzion Pharma Co.,Ltd. announces an Equity Buyback for 106,007 shares.
2014Mezzion Pharma Co. Ltd. Appoints Jefferson Gregory to its Board of Directors
2014Dong-A PharmTech Co. Ltd. agreed to acquire medical equipment sales business of Top Med..
2014Dong-hyun Park, Chief Executive Officer of Dong-A PharmTech acquired 0.06% stake in Don..
2012Dong-A PharmTech Co. Ltd. closed an Equity Buyback in the amount of KRW3989.69 mm
2012Dong-A PharmTech Co. Ltd. announces an Equity Buyback
2012Dong-A PharmTech Co. Ltd.'s Equity Buyback in the amount of KRW5000 mm has expired
2012Dong-A PharmTech Co. Ltd.'s Equity Buyback has expired
2012Dong-A PharmTech Co. Ltd. announces an Equity Buyback
2012Dong-A PharmTech Co. Ltd. announces an Equity Buyback in the amount of KRW5000 mm
Prochain événement sur MEZZION PHARMA CO.,LTD.